Cited by 271Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver Diseases and Immunity

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Non‐alcoholic steatohepatitis: another disease of affluence

Open access

James, *Oliver, Day, Christopher·1999·The Lancet

DOI 10.1016/s0140-6736(99)00163-4

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(99)00163-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Self-citation
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
Self-citation
Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 818
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M., Farrell, G. C., Hall, P. D. L. Μ., Ingelman‐Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 613
Hepatic steatosis: Innocent bystander or guilty party?
Day, C. P., & James, O. (1998) · Hepatology · doi:10.1002/hep.510270601 · Cited by 395
Self-citation
Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance
James, O., & Day, C. P. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80073-1 · Cited by 370
Self-citation

Show all 15 references

Research works printed but not linked: 1

Younossi, 1998, Patient characteristics predicting cirrhosis and death in non-alcoholic steatohepatitis, Hepatology, 28, 303A

Sorted by citations

Items 101–200 of 270

Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption
Lainé, F., Bendavid, C., Moirand, R., Tessier, S., Perrin, M., Guillygomarc’h, A., Guyader, D., Calon, E., Renault, A., Brissot, P., et al. (2004) · Hepatology · doi:10.1002/hep.20219 · Cited by 62
Effects of ultrafine petrol exhaust particles on cytotoxicity, oxidative stress generation, DNA damage and inflammation in human A549 lung cells and murine RAW 264.7 macrophages
Mohan, D., Soundararajan, N., Rajasekar, A., & Devasena, T. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2014.08.003 · Cited by 62
Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution
Lonardo, A., & Trande, P. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02226.x · Cited by 61
Tamoxifen-induced Nonalcoholic Steatohepatitis in Breast Cancer Patients Treated with Adjuvant Tamoxifen.
Nemoto, Y., Saibara, T., Ogawa, Y., ZHANG, T., Xu, N., Ono, M., Akisawa, N., Iwasaki, S., Maeda, T., & Onishi, S. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.345 · Cited by 55
Fatty infiltration of the liver
Pilleul, F., Chave, G., Dumortier, J., Scoazec, J., & Valette, P. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)82179-7 · Cited by 54
L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function
Xia, Y., Li, Q., Zhong, W., Dong, J., Wang, Z., & Wang, C. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-31 · Cited by 53
The potential role of adenosine in the pathophysiology of the insulin resistance syndrome
Bakker, S. J. L., Gans, R. O. B., ter Maaten, J. C., Teerlink, T., Westerhoff, H. V., & Heine, R. J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00745-0 · Cited by 52
Non-alcoholic fatty liver disease: a diabetologist’s perspective
Pappachan, J. M., Antonio, F. A., Edavalath, M., & Mukherjee, A. (2013) · Endocrine · doi:10.1007/s12020-013-0087-8 · Cited by 50
Metabolic syndrome and ALT: a community study in adult Koreans
Jeong, S.-K., Nam, H.-S., Rhee, J.-A., Shin, J.-H., Kim, J.-M., & Cho, K.-H. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802698 · Cited by 50
Saponins, especially platycodin D, from Platycodon grandiflorum modulate hepatic lipogenesis in high-fat diet-fed rats and high glucose-exposed HepG2 cells
Hwang, Y. P., Choi, J. H., Kim, H. G., Khanal, T., Song, G., Nam, M. S., Lee, H.-S., Chung, Y., Lee, Y. C., & Jeong, H. G. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.01.001 · Cited by 49
Second World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1518 · Cited by 50
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 49
Non-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 48
The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding
Henriksen, B. S., Curtis, M. E., Fillmore, N., Cardon, B. R., Thomson, D. M., & Hancock, C. R. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-29 · Cited by 49
The emerging role of mast cells in liver disease
Jarido, V., Kennedy, L. L., Hargrove, L. A., Demieville, J., Thomson, J., Stephenson, K., & Francis, H. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00333.2016 · Cited by 48
Lack of peroxisome proliferator-activated receptor ? in mice enhances methionine and choline deficient diet-induced steatohepatitis
Kashireddy, P. V. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.06.004 · Cited by 47
Is bacterial ash the flash that ignites NASH?
Farrell, G. C. (2001) · Gut · doi:10.1136/gut.48.2.148 · Cited by 47
Postprandial insulin secretion pattern is associated with histological severity in non‐alcoholic fatty liver disease patients without prior known diabetes mellitus
Kimura, Y., Hyogo, H., Ishitobi, T., Nabeshima, Y., Arihiro, K., & Chayama, K. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06567.x · Cited by 43
Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis
Deguti, M. M., Sipahi, A. M., Gayotto, L. C. C., Palácios, S. A., Bittencourt, P. L., Goldberg, A. C., Laudanna, A. A., Carrilho, F. J., & Cançado, E. L. R. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000600009 · Cited by 43
Effects of Radiation on Fatty Liver and Metabolic Coronary Risk Factors among Atomic Bomb Survivors in Nagasaki
Akahoshi, M., AMASAKI, Y., Soda, M., Hida, A., Imaizumi, M., Nakashima, E., Maeda, R., Seto, S., & Yano, K. (2003) · Hypertension Research · doi:10.1291/hypres.26.965 · Cited by 40
Models of Alcoholic Liver Disease in Rodents: A Critical Evaluation
Hall, P. D. L. Μ., Lieber, C. S., DeCarli, L. M., French, S. W., Lindros, K. O., inen, H. A. J. R., Bode, C., Parlesak, A., & Bode, J. C. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00041 · Cited by 42
Liver Function Tests
Knight, J. A. (2005) · Journal of Infusion Nursing · doi:10.1097/00129804-200503000-00004 · Cited by 44
Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality
Bengtsson, B., Koppeschaar, H. P. F., Abs, R., Bennmarker, H., Hernberg-Ståhl, E., Westberg, B., Wilton, P., Monson, J. P., Feldt‐Rasmussen, U., & Wüster, C. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6171-1 · Cited by 40
Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium l-glutamate in rats
Lazarin, M. D. O., Ishii‐Iwamoto, E. L., Yamamoto, N. S., Constantin, R. P., Garcia, R. F., da Costa, C. E. M., Vitoriano, A. D. S., de Oliveira, M. C., & Salgueiro‐Pagadigorria, C. L. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.07.003 · Cited by 40
Relationship of Adiposity to Subclinical Atherosclerosis in Obese Patients with Type 2 Diabetes
Hegazi, R. A. F., Sutton‐Tyrrell, K., Evans, R. W., Kuller, L. H., Belle, S. H., Yamamoto, M. E., Edmundowicz, D., & Kelley, D. E. (2003) · Obesity Research · doi:10.1038/oby.2003.212 · Cited by 39
A water-soluble extract of Petalonia binghamiae inhibits the expression of adipogenic regulators in 3T3-L1 preadipocytes and reduces adiposity and weight gain in rats fed a high-fat diet
Kang, S., Kim, M.-H., Shin, H., Kim, H.-M., Hong, Y.-S., Park, J., Ko, H., Lee, N., Chung, W.-S., & Kim, S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.008 · Cited by 38
Second World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1821 · Cited by 37
Suppressive effects of germinated buckwheat on development of fatty liver in mice fed with high-fat diet
Choi, I., Seog, H.-M., Park, Y., Kim, Y., & Choi, H. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.05.002 · Cited by 37
Management of Nonalcoholic Steatohepatitis
Agrawal, S., & Bonkovsky, H. L. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200209000-00011 · Cited by 36
Cu,Zn-SOD deficiency induces the accumulation of hepatic collagen
Sakiyama, H., Fujiwara, N., 米岡由佳, Yoshihara, D., Eguchi, H., & Suzuki, K. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1164856 · Cited by 35
Fatty Liver Disease
TINIAKOS, D. G., Anstee, Q. M., & Burt, A. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-7020-6697-9.00005-4 · Cited by 35
Resistance training prevents liver fat accumulation in ovariectomized rats
Corriveau, P., Paquette, A., Brochu, M., Prud’homme, D., RABASA-LHORET, R. P. R., & Lavoie, J.-M. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.005 · Cited by 33
Hepatic mast cell concentration directly correlates to stage of fibrosis in NASH
Lombardo, J. L., Broadwater, D. R., Collins, R., Cebe, K. M., Brady, R. O., & Harrison, S. A. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.11.029 · Cited by 32
Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma
Kan, H., Yamagishi, S., Ojima, A., Fukami, K., Ueda, S., Takeuchi, M., Hyogo, H., Aikata, H., & Chayama, K. (2014) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21797 · Cited by 32
A new marker for lipid peroxidation: serum paraoxonase activity in non-alcoholic steatohepatitis.
Başkol, M., Başkol, G., Denız, K., Özbakır, Ö., & Yücesoy, M. (2005) · The Turkish Journal of Gastroenterology · Cited by 32
Effects of Short–Term Leptin Exposure on Triglyceride Deposition in Rat Liver
Roden, M., Anderwald, C. H., Fürnsinn, C., Waldhäusl, W. K., & Lohninger, A. (2000) · Hepatology · doi:10.1053/jhep.2000.18712 · Cited by 31
Non‐invasive assessment of liver steatosis in non‐alcoholic fatty liver disease
Kan, H., Kimura, Y., Hyogo, H., Fukuhara, T., Fujino, H., Naeshiro, N., Honda, Y., Kawaoka, T., Tsuge, M., Hiramatsu, A., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12330 · Cited by 30
Anti-obesity effect ofTriticum aestivumsprout extract in high-fat-diet-induced obese mice
Im, J.-Y., Ki, H., Xin, M., Kwon, S.-U., Kim, Y. H., Kim, D., Hong, S.-P., Jin, J., & Lee, Y. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1006567 · Cited by 29
Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis
Yamauchi, N., Itoh, Y., Tanaka, Y., Mizokami, M., Minami, M., Morita, A., Toyama, T., Yamaguchi, K., Fujii, H., & Okanoue, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1361-y · Cited by 29
Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
Oneta, C. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.10001 · Cited by 29
NONALCOHOLIC STEATOHEPATITIS AND INSULIN RESISTANCE : INTERFACE BETWEEN GASTROENTEROLOGISTS AND ENDOCRINOLOGISTS
Scheen, A. J., & Luyckx, F. (2003) · Acta Clinica Belgica · doi:10.1179/acb.2003.58.2.006 · Cited by 27
2D Gadolinium Oxide Nanoplates as T1 Magnetic Resonance Imaging Contrast Agents
Stinnett, G. R., Taheri, N., Villanova, J., Bohloul, A., Guo, X., Esposito, E. P., Xiao, Z., Stueber, D. D., Avendaño, C., Decuzzi, P., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001780 · Cited by 29
Neonatal intake of oleanolic acid attenuates the subsequent development of high fructose diet-induced non-alcoholic fatty liver disease in rats
Nyakudya, T. T., Mukwevho, E., Nkomozepi, P., & Erlwanger, K. H. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000259 · Cited by 28
Miller Fisher Variant of Guillain‐Barre Syndrome Associated with Lactic Acidosis and Stavudine Therapy
Shah, S. S., Rodriguez, T., & McGowan, J. P. (2003) · Clinical Infectious Diseases · doi:10.1086/374935 · Cited by 28
Is radiation nephropathy caused by yttrium-90?
Otte, A., Weiner, S. M., & Cybulla, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08002-9 · Cited by 28
Nutritional and Metabolic Liver Diseases
Sherlock, F. S., & BSc, J. D. (2001) · Wiley eBooks · doi:10.1002/9780470986820.ch25 · Cited by 27
Suppression of autophagy sensitizes Kupffer cells to endotoxin
Fukada, H., Yamashina, S., Izumi, K., Komatsu, M., Tanaka, K., Ikejima, K., & Watanabe, S. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01024.x · Cited by 27
Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach: Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, Leptin-deficient Micenat Med 2000;6:998–1003
Hookman, P., & Barkin, J. S. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07670.x · Cited by 27
Parallel Reversibility of Biological Markers of the Metabolic Syndrome and Liver Steatosis after Gastroplasty-Induced Weight Loss in Severe Obesity
Luyckx, F., Scheen, A. J., Desaive, C., Thiry, A., & Lefèbvre, P. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6171-4 · Cited by 27
Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH
Takeuchi, M., Sakai, A., Takata, T., Ueda, T., Takino, J.-I., Tsutsumi, M., Hyogo, H., & Yamagishi, S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.02.002 · Cited by 26
Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese mice
Rivera‐Gonzalez, O., Wilson, N. A., Coats, L. E., Taylor, E. B., & Speed, J. S. (2021) · Clinical Science · doi:10.1042/cs20210549 · Cited by 26
Influence of the rs738409 polymorphism in patatin‐like phospholipase 3 on the treatment efficacy of non‐alcoholic fatty liver disease with type 2 diabetes mellitus
Kan, H., Hyogo, H., Ochi, H., Hotta, K., Fukuhara, T., Kobayashi, T., Naeshiro, N., Honda, Y., Kawaoka, T., Tsuge, M., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12552 · Cited by 26
Combined ‘En Bloc’ Liver and Pancreas Transplantation in Patients with Liver Disease and Type 1 Diabetes Mellitus
Pirenne, J., Deloose, K. R., Coosemans, W., Aerts, R., Gelder, F. V., Kuypers, D. R. J., Maes, B., Verslype, C., Yap, P. S. H., Steenbergen, W. V., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00588.x · Cited by 26
Factors Associated with the Presence of Nonalcoholic Steatohepatitis in Patients with Chronic Hepatitis C
Solis-Herruzo, J. A., Pérez-Carreras, M., Rivas, E., Fernández-Vázquez, I., Garfia, C., Bernardos, E., Castellano, G., & Colina, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41059.x · Cited by 26
Emerging drugs for non-alcoholic fatty liver disease
Federico, A., Niosi, M., Blanco, C. D. V., & Loguercio, C. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.145 · Cited by 25
Non-alcoholic steatohepatitis
Saibara, T., Onishi, S., Ogawa, Y., Yoshida, S., & Enzan, H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76071-2 · Cited by 25
Factor analysis of risk variables associated with low-grade inflammation
Aronson, D., Avizohar, O., Levy, Y., Bartha, P., Jacob, G., & Markiewicz, W. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.12.008 · Cited by 24
The latest idea in NAFLD/NASH pathogenesis
Ono, M., Okamoto, N., & Saibara, T. (2010) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-010-0182-9 · Cited by 23
Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver
Serin, E., Özer, B., G�m�rd�l�, Y., Kayaselçuk, F., Kul, K., & Boyacıoğlu, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1084-5 · Cited by 23
Non-alcoholic steatohepatitis (NASH)
Sorrell, M. F., & Mukherjee, S. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0047-9 · Cited by 23
Serum triglycerides, the liver and the pancreas
Miller, J. P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00006 · Cited by 23
Death by lipids: The role of small nucleolar RNAs in metabolic stress
Schaffer, J. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.aw120.011105 · Cited by 21
Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
Ono, M., Ogasawara, M., Hirose, A., Mogami, S., Ootake, N., Aritake, K., Higuchi, T., Okamoto, N., Sakamoto, S., Yamamoto, M., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0852-8 · Cited by 22
Results of Bariatric Surgery
Hansen, E. N., Torquati, A., & Abumrad, N. N. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111242 · Cited by 22
Obesity: a cause of steatohepatitis in children
Koçak, N., Yüce, A., Gürakan, F., & Özen, H. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00751-6 · Cited by 22
Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients
Hewavisenthi, S. D. S., Dassanayaka, A. S., & Silva, H. D. (2009) · Ceylon Medical Journal · doi:10.4038/cmj.v50i3.1429 · Cited by 21
Visceral fat predominance is associated with non‐alcoholic fatty liver disease in J apanese women with metabolic syndrome
Sogabe, M., Okahisa, T., Tsujigami, K., Fukuno, H., Hibino, S., & Yamanoi, A. (2013) · Hepatology Research · doi:10.1111/hepr.12146 · Cited by 21
Glucose intolerance and serum aminotransferase activities in Japanese men
Miyake, Y., Eguchi, H., Shinchi, K., Oda, T., Sasazuki, S., & Kono, S. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00323-9 · Cited by 21
Hepatoprotective and antioxidant activities of extracts from Salvia—Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice
Liu, Y., Song, H., Wang, L., Xu, H., Shu, X., Zhang, L. R., Li, Y., Li, D., & Ji, G. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0315-x · Cited by 21
Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcohol steatohepatitis
Susca, M., Grassi, A., Zauli, D., Volta, U., Lenzi, M., Marchesini, G., Bianchi, F. B., & Ballardini, G. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80694-0 · Cited by 20
High-throughput and rapid quantification of lipids by nanoflow UPLC-ESI-MS/MS: application to the hepatic lipids of rabbits with nonalcoholic fatty liver disease
Byeon, S. K., Lee, J. C., Chung, B. C., Seo, H. S., & Moon, M. H. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9592-y · Cited by 20
Aerobic exercise: a potential therapeutic intervention for patients with liver disease
Bergasa, N. V., Mehlman, J. K., & Bir, K. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.041 · Cited by 20
Clinical features and risk factors of patients with fatty liver in Guangzhou area
Chen, Q., Chen, H., Huang, K.-H., Zhong, Y., Han, J., Zhu, Z., & Zhou, X.-D. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i6.899 · Cited by 20
Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation
Swain, M., Nath, P., Parida, P. K., Narayan, J., Padhi, P. K., Pati, G. K., Singh, A., Misra, B., Misra, D., Kar, S. K., et al. (2016) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-016-0612-7 · Cited by 19
Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia
Fan, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i15.2346 · Cited by 19
Low socioeconomic status and coronary artery disease
Saibara, T., Nozaki, Y., Nemoto, Y., Ono, M., & Onishi, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08005-4 · Cited by 19
Aromatase-deficient (ArKO) mice are retrieved from severe hepatic steatosis by peroxisome proliferator administration
Yoshikawa, T. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00145-0 · Cited by 18
Effects of estrogen on Stress Responses in Women
Komesaroff, P. A., Krishna, S., & Esler, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6171-3 · Cited by 17
Non-alcoholic steatohepatitis
Luyckx, F., Scheen, A. J., & Lefèbvre, P. J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76069-4 · Cited by 17
Elevated urine neopterin levels in nonalcoholic steatohepatitis
Yaman, H., Çakır, E., Özcan, Ö., Yeşilova, Z., Özcan, A., Akgül, E. Ö., Erbil, M. K., Bağcı, S., Bilgi, C., & Dağalp, K. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.10.008 · Cited by 16
Time course of changes inin vitrolipolysis of intra-abdominal fat depots in relation to high-fat diet-induced hepatic steatosis in rats
Collin, P., Chapados, N. A., Dufresne, É., Corriveau, P., Imbeault, P., & Lavoie, J.-M. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061775 · Cited by 16
Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease
Tokita, H. (2001) · Hepatology Research · doi:10.1016/s1386-6346(00)00124-8 · Cited by 15
Time-course microarrays reveal early activation of the immune transcriptome in a choline-deficient mouse model of liver injury
Mitsumoto, K., Watanabe, R., Nakao, K., Yonenaka, H., Hashimoto, T., Katô, N., Kumrungsee, T., & Yanaka, N. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.009 · Cited by 15
Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases
Kahraman, A., Miller, M., Gieseler, R. K. H., Gerken, G., Scolaro, M. J., & Canbay, A. E. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200601000-00018 · Cited by 15
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases
Daijo, K., Nakahara, T., Inagaki, Y., Nanba, M., Nishida, Y., Uchikawa, S., Kodama, K., Oya, K., Morio, K., Fujino, H., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14968 · Cited by 14
Effects of estrogen and androgen deprivation on the progression of non‐alcoholic steatohepatitis (NASH) in male Sprague–Dawley rats
Mu, Y., Ruiping, S., Zhang, H., Dong, B., Huang, C., Lin, W., Li, D., & Li, X. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2009.00512.x · Cited by 14
Hair Selenium Levels in Hepatic Steatosis Patients
Pan, D., & Huang, H. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9624-9 · Cited by 12
Fatty Liver Disease
Brunt, E. M., & TINIAKOS, D. G. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50044-8 · Cited by 12
Oral glucose tolerance test in children and adolescents: Positives and pitfalls
Conwell, L. S., & Batch, J. (2004) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2004.00487.x · Cited by 12
Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality
Ba, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4291 · Cited by 12
Efficacy of probucol for the treatment of non‐alcoholic steatohepatitis with dyslipidemia: An open‐label pilot study
Ishitobi, T., Hyogo, H., Tokumo, H., Arihiro, K., & Chayama, K. (2013) · Hepatology Research · doi:10.1111/hepr.12135 · Cited by 11
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation
Garcia, R. F. L., Morales, E. V. B., Garcia, C. E., Saksena, S., Hübscher, S. G., & Elias, E. (2001) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032001000400007 · Cited by 11
Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non‐alcoholic fatty liver disease and cardiovascular disease
Ishitobi, T., Hyogo, H., Kan, H., Hiramatsu, A., Arihiro, K., Aikata, H., & Chayama, K. (2014) · Hepatology Research · doi:10.1111/hepr.12382 · Cited by 10
Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
Yoon, C.-Y., Lee, M., Kim, S. U., Lim, H., Chang, T. I., Kee, Y. K., Han, S. G., Han, I. M., Kwon, Y. E., Park, K. S., et al. (2017) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2017.36.1.48 · Cited by 10
Preventive Effects of Flavonoid Extracts from I lex hainanensis M err. on Rats with Hepatic Steatosis Induced by a High‐Fat Diet
Wei, X., Chen, X., Fang, R.-T., Sun, X., Zhu, C., Yang, J., Xue, X., & Wang, Q. (2012) · Drug Development Research · doi:10.1002/ddr.21014 · Cited by 9
Insulin Treatment in Type 2 Diabetes
Ryysy, L. (2001) · Työväentutkimus Vuosikirja · Cited by 9
Renal dysfunction in liver cirrhosis
Sargent, S., & Martin, W. (2006) · British Journal of Nursing · doi:10.12968/bjon.2006.15.1.20302 · Cited by 8
The metabolic syndrome revisited
Lefèbvre, P. J. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00141-9 · Cited by 8
Nutritional aspects of non‐alcoholic steatohepatitis treatment
Yunianingtias, D., & Volker, D. H. (2006) · Nutrition & Dietetics · doi:10.1111/j.1747-0080.2006.00054.x · Cited by 8
Fundamento molecular de la esteatosis hepática asociada a la obesidad
Buqué, X., Aspichueta, P., & Ochoa, B. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000900007 · Cited by 9

Authors: James, *., & Day, C.
Affiliations: Newcastle University (GB)
ORCID: Day, Christopher
Venue: The Lancet
Publisher: Elsevier BV
Published: 1999-05
Volume: 353
Issue: 9165
Pages: 1634-1636
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(99)00163-4
OpenAlex: W2075783257
Cited by: 271
References: 15
Citations by year: 2026: 1 · 2024: 1 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 7 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 8 · 2013: 17 · 2012: 9
FWCI: 17.97
Type: journal article
Language: en
Open access: green
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Newcastle University ePrints (Newcastle Univesity)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords: nonalcoholic steatohepatitis, liver dysfunction, alcohol consumption, prevalence, health screening
MeSH terms: Diabetes Mellitus, Type 2, Fatty Liver, Hepatitis, Humans, Liver, Obesity, Lipid Peroxidation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Non‐alcoholic steatohepatitis: another disease of affluence

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks